Dr. Elaine Shum, MD
Claim this profileNYU Langone Health
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
17 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage IV
Stage II
2Non-Small Cell Lung Cancer
Stage III
Stage IV
MET positive
Affiliated Hospitals
Clinical Trials Elaine Shum, MD is currently running
MYTX-011
for Lung Cancer
This trial is testing MYTX-011, a new medication that targets advanced lung cancer cells with specific genetic markers. It uses an antibody to guide a powerful drug directly to the cancer cells to kill them.
Recruiting1 award Phase 19 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Elaine Shum, MD
Clinical Trial Related5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Elaine Shum, MD has experience with
- Atezolizumab
- PD-1 Inhibitor
- NC318
- Osimertinib
- Ramucirumab
- Cisplatin
Breakdown of trials Elaine Shum, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elaine Shum, MD specialize in?
Elaine Shum, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Elaine Shum, MD currently recruiting for clinical trials?
Yes, Elaine Shum, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Elaine Shum, MD has studied deeply?
Yes, Elaine Shum, MD has studied treatments such as Atezolizumab, PD-1 inhibitor, NC318.
What is the best way to schedule an appointment with Elaine Shum, MD?
Apply for one of the trials that Elaine Shum, MD is conducting.
What is the office address of Elaine Shum, MD?
The office of Elaine Shum, MD is located at: NYU Langone Health, New York, New York 10016 United States. This is the address for their practice at the NYU Langone Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.